BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31285543)

  • 1. FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation.
    Richter KT; Kschonsak YT; Vodicska B; Hoffmann I
    Cell Death Differ; 2020 Feb; 27(2):758-772. PubMed ID: 31285543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage.
    Hänle-Kreidler S; Richter KT; Hoffmann I
    J Biol Chem; 2022 Dec; 298(12):102703. PubMed ID: 36395886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2-AKT signaling in pancreatic cancer.
    Zhang MX; Wang H; Sun GP
    Cell Biol Int; 2020 Sep; 44(9):1900-1910. PubMed ID: 32437091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXW7 is involved in Aurora B degradation.
    Teng CL; Hsieh YC; Phan L; Shin J; Gully C; Velazquez-Torres G; Skerl S; Yeung SC; Hsu SL; Lee MH
    Cell Cycle; 2012 Nov; 11(21):4059-68. PubMed ID: 23095493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCF
    Bajpai S; Jin HR; Mucha B; Diehl JA
    Cancer Biol Ther; 2022 Dec; 23(1):348-357. PubMed ID: 35438057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.
    Wang Y; Zhang P; Wang Y; Zhan P; Liu C; Mao JH; Wei G
    Cancer Res; 2017 Apr; 77(8):1983-1996. PubMed ID: 28209614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin ligase FBXW7 targets the centriolar assembly protein HsSAS-6 for degradation and thereby regulates centriole duplication.
    Badarudeen B; Gupta R; Nair SV; Chandrasekharan A; Manna TK
    J Biol Chem; 2020 Apr; 295(14):4428-4437. PubMed ID: 32086376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.
    Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI
    J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FBXW7 tumor suppressor inhibits breast cancer proliferation and promotes apoptosis by targeting MTDH for degradation.
    Chen X; Li XY; Long M; Wang X; Gao ZW; Cui Y; Ren J; Zhang Z; Liu C; Dong K; Zhang H
    Neoplasma; 2018; 65(2):201-209. PubMed ID: 29534580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
    Wang J; Wang H; Peters M; Ding N; Ribback S; Utpatel K; Cigliano A; Dombrowski F; Xu M; Chen X; Song X; Che L; Evert M; Cossu A; Gordan J; Zeng Y; Chen X; Calvisi DF
    J Hepatol; 2019 Oct; 71(4):742-752. PubMed ID: 31195063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination.
    Zhu H; Wang X; Zhou X; Lu S; Gu G; Liu C
    Lab Invest; 2022 Nov; 102(11):1203-1213. PubMed ID: 35840806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors.
    Xu M; Zhu C; Zhao X; Chen C; Zhang H; Yuan H; Deng R; Dou J; Wang Y; Huang J; Chen Q; Jiang B; Yu J
    Oncotarget; 2015 Jan; 6(2):979-94. PubMed ID: 25460509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.
    Onoyama I; Suzuki A; Matsumoto A; Tomita K; Katagiri H; Oike Y; Nakayama K; Nakayama KI
    J Clin Invest; 2011 Jan; 121(1):342-54. PubMed ID: 21123947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation.
    Babaei-Jadidi R; Li N; Saadeddin A; Spencer-Dene B; Jandke A; Muhammad B; Ibrahim EE; Muraleedharan R; Abuzinadah M; Davis H; Lewis A; Watson S; Behrens A; Tomlinson I; Nateri AS
    J Exp Med; 2011 Feb; 208(2):295-312. PubMed ID: 21282377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.
    Koo J; Wu X; Mao Z; Khuri FR; Sun SY
    J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of FBXW7 in Gynecologic Malignancies.
    Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Suleiman S; Vasileva-Slaveva M; Yordanov A; Pentimalli F; Giordano A; Calleja-Agius J
    Cells; 2023 May; 12(10):. PubMed ID: 37408248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.
    Yu J; Zhang Y; Li L; Xiang Y; Yao X; Zhao Y; Cai K; Li M; Li Z; Luo Z
    Acta Biomater; 2023 Oct; 169():434-450. PubMed ID: 37516418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer.
    Fang L; Yang Z; Zhou J; Tung JY; Hsiao CD; Wang L; Deng Y; Wang P; Wang J; Lee MH
    Mol Cancer Ther; 2015 Jun; 14(6):1476-87. PubMed ID: 25855785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.
    Galindo-Moreno M; Giráldez S; Limón-Mortés MC; Belmonte-Fernández A; Reed SI; Sáez C; Japón MÁ; Tortolero M; Romero F
    FASEB J; 2019 Oct; 33(10):11420-11430. PubMed ID: 31337255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer.
    Ou B; Zhao J; Guan S; Wangpu X; Zhu C; Zong Y; Ma J; Sun J; Zheng M; Feng H; Lu A
    Cancer Lett; 2016 Oct; 380(2):457-466. PubMed ID: 27423313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.